F/M Investments’s ANI Pharmaceuticals ANIP Stock Holding History

F/M Investments’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$217K	Hold	2,865	–	–	0.01%	341
2026 Q1	$205K	Sell	2,865 -64,938	-96%	-$5.07M	0.01%	330
2025 Q4	$5.35M	Buy	67,803 +11,753	+21%	+$1.02M	0.2%	119
2025 Q3	$5.13M	Sell	56,050 -1,145	-2%	-$93.4K	0.2%	119
2025 Q2	$3.73M	Buy	57,195 +121	+0.2%	+$7.88K	0.14%	164
2025 Q1	$3.81M	Buy	57,074 +761	+1%	+$45.5K	0.15%	150
2024 Q4	$3.11M	Sell	56,313 -5,469	-9%	-$314K	0.11%	169
2024 Q3	$14.1M	Buy	+61,782	New	+$3.77M	0.44%	57

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

GACM

Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

F/M Investments's ANIP Position: Q2 2026 in Review

F/M Investments held its ANI Pharmaceuticals (ANIP) position steady in Q2 2026 at 2,865 shares worth $217K. The position accounts for 0.01% of the portfolio, ranked #341.

F/M Investments first reported a position in ANIP in Q3 2024 and has held it in 8 quarters since. The position peaked at $14.1M in Q3 2024. 308 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

F/M Investments held 2,865 shares of ANI Pharmaceuticals worth $217K as of Q2 2026.
F/M Investments left its ANI Pharmaceuticals share count unchanged in Q2 2026.
ANI Pharmaceuticals made up 0.01% of F/M Investments's portfolio in Q2 2026, its #341 holding.
F/M Investments first reported a position in ANI Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
F/M Investments's ANI Pharmaceuticals position peaked at $14.1M in Q3 2024.
308 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on F/M Investments's 13F filing for Q2 2026, filed 5 Aug 2026.